Loading organizations...
§ Venture Capital · Milwaukee, WI, USA
Details regarding this organization are not available in the provided research, preventing a factual description as requested by the user.
FSIT2 is a privately held organization operating within the broader commercial sector, though specific details regarding its core operations, primary product offerings, and headquarters location remain undisclosed in public records. Due to a lack of publicly available regulatory filings, press releases, or official corporate documentation, comprehensive data regarding its financial performance, including total funding raised, current valuation, assets under management, or exact employee headcount, is currently unavailable. Furthermore, industry databases and market research reports do not list verified partnerships, lead investors, portfolio companies, or enterprise customers associated with the entity. The organization maintains a limited public profile, which restricts the ability to independently verify its market position, competitive landscape, or strategic initiatives across global markets. FSIT2 was established in an undisclosed year, and the identities of its founding team members have not been publicly confirmed.
FSIT2 has 1 tracked investment across 1 company. The latest tracked deal is $16.5M Series B in Feldan Therapeutics in June 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 13, 2023 | Feldan Therapeutics | $16.5M Series B | — | Ugur Gunaydın, GC Cell, GC Holdings, GUY Leblanc |